BCYC BICYCLE THERAPEUTICS PLC: institutional ownership and insider trading
101 funds reported holding $160M of BICYCLE THERAPEUTICS PLC in their latest 13F filings; in Q2 2026 funds net sold $427K, with 18 new positions and 13 funds selling out; over the last 12 months insiders bought $0 and sold $517K on the open market; over its last four quarters it reported revenue of $61.2M and net income of −$190M.
BCYC revenue and earnings
- Quarter ended Jun 30, 2026: revenue $629K, net income −$50.3M, EPS -0.72
- Quarter ended Mar 31, 2026: revenue $887K, net income −$60.8M, EPS -0.87
- Quarter ended Dec 31, 2025: revenue $48.0M, net income −$20.2M, EPS -0.29
- Quarter ended Sep 30, 2025: revenue $11.7M, net income −$59.1M, EPS -0.85
Famous investors holding BCYC
- Renaissance Technologies (Renaissance Technologies): $6.50M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.66M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.35M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.84M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $108K, 0.0% of the portfolio
Largest institutional holders of BCYC
- BAKER BROS. ADVISORS LP — $46.2M
- FCPM III SERVICES B.V. — $14.7M
- ARMISTICE CAPITAL, LLC — $14.4M
- Long Focus Capital Management, LLC — $14.0M
- ACADIAN ASSET MANAGEMENT LLC — $8.32M
- RENAISSANCE TECHNOLOGIES LLC — $6.50M
- GSK plc (GSK, GLAXF) — $6.49M
- PRICE T ROWE ASSOCIATES INC /MD/ — $3.83M
- MARSHALL WACE, LLP — $3.38M
- Qube Research & Technologies Ltd — $3.29M
Recent BCYC insider trades
- Oct 5, 2026: Perry Jennifer Scott sold 356 shares ($1.34K)
- Oct 5, 2026: Skynner Michael sold 2,445 shares ($8.54K)
- Oct 5, 2026: Lee Kevin sold 7,805 shares ($27.2K)
- Oct 5, 2026: Thompson Travis Alvin sold 972 shares ($3.38K)
5%+ owners
- Armistice Capital, LLC: 6.7% (Schedule 13G/A, filed Aug 14, 2026)
- LONG FOCUS CAPITAL MANAGEMENT, LLC: 6.6% (Schedule 13G, filed May 15, 2026)
Who owns the most BCYC stock?
The largest institutional holders of BICYCLE THERAPEUTICS PLC in the latest 13F filings are BAKER BROS. ADVISORS LP ($46.2M), FCPM III SERVICES B.V. ($14.7M), ARMISTICE CAPITAL, LLC ($14.4M).
Are insiders buying or selling BCYC?
Over the last 12 months insiders bought $0 and sold $517K of BICYCLE THERAPEUTICS PLC stock on the open market (SEC Form 4).
Which famous investors own BCYC?
Renaissance Technologies, Ken Griffin, Izzy Englander, Two Sigma, D. E. Shaw.
What was BCYC's revenue last quarter?
BICYCLE THERAPEUTICS PLC reported revenue of $629K for the quarter ended June 30, 2026, with net income of −$50.3M.
Which ETFs hold BCYC?
2 ETFs and mutual funds hold it among their top 100 positions, including SBIO, MEDX.